Menu

Coya Therapeutics, Inc. COYA

Full chart Compare
Set alert

Price alert · COYA

All alert types
2.99 USD +0.18 (+6.41%)

At closeNov 6, 2026, 4:26 PM EST

2.99 0.00 0.00%

After hours · Nov 6, 4:26 PM ET

2.74 Day range 3.03
2.81 52-week range 6.51
YTD
-48.45%
1 year
-48.09%

Revenue & Expenses

Other Income → Expenses: $1.33MExpenses → Selling, General & Admin: $11.45MExpenses → Research & Development: $16.73MExpenses → Other Operating Expenses: $2.32MExpenses → Income Tax: $3.09KGross Profit → Expenses: $7.95MRevenue → Gross Profit: $7.95MNet Loss → Expenses: $21.23MOther Income$1.33MGross Profit$7.95MNet Loss$21.23MExpenses$30.50MSelling, General & Admin$11.45MResearch & Development$16.73MOther Operating Expenses$2.32MIncome Tax$3.09KRevenue$7.95M

Latest period ending Dec 31, 2025 · select a line to chart its full history

COYA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
7.95M3.55M6.00M00
7.95M3.55M6.00M00
-22.56M-17.25M-7.90M-9.81M-4.87M
-21.23M-14.88M-7.99M-12.24M-4.89M
-1.27-0.98-0.79-4.73-1.89
COYA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
46.82M38.34M32.63M5.93M4.34M
49.95M44.35M41.26M8.40M4.79M
6.92M4.77M5.63M16.79M1.15M
43.03M39.58M35.64M-8.39M3.64M
COYA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-10.74M-10.29M-11.19M-7.24M-3.90M
-1.16M-25.00K-543.19K-525.00K-136.80K
20.39M16.03M38.43M9.36M-340.58K
8.48M5.71M26.69M1.59M-4.38M